Skip to content

Low-level laser and extracorporeal shockwave in patients with carpal tunnel syndrome

The comparison of effectiveness of low-level laser and extracorporeal shockwave in patients with carpal tunnel syndrome

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20220504054734N1
Enrollment
54
Registered
2022-06-30
Start date
2022-07-21
Completion date
Unknown
Last updated
2022-08-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Carpal tunnel syndrome. Carpal tunnel syndrome

Interventions

Intervention 1: Intervention group: This group will receive Low-level laser , five sessions per week, for two weeks.Each session will last for 5 minutes. Patients will be asked to lay in sitting p

Sponsors

Tehran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 60 Years

Inclusion criteria

Inclusion criteria: Patients with carpal tunnel syndrome Age between 20 and 60

Exclusion criteria

Exclusion criteria: History of fracture and dislocation in wrist and hand complex during the last 3 months History of surgery in wrist and hand complex during the last 6 months Cervical radiculopathy and thoracic outlet syndrome Pregnancy Receiving coricosteriod injection and physiotherapy treatment during the last 3 months Neurological and systemic diseases, such as rheumatoid arthritis, Parkinson, Multiple Sclerosis

Design outcomes

Primary

MeasureTime frame
Pain. Timepoint: At baseline, after two weeks( the end of the treatment), after a one-week follow-up period. Method of measurement: Visual analog scale.;Function. Timepoint: At baseline, after two weeks( the end of the treatment), after a one-week follow-up period. Method of measurement: Boston Carpal Tunnel Syndrome Questionnaire.;Grip power. Timepoint: At baseline, after two weeks( the end of the treatment), after a one-week follow-up period. Method of measurement: Dynamometer.;Pinch power. Timepoint: At baseline, after two weeks( the end of the treatment), after a one-week follow-up period. Method of measurement: Dynamometer.

Secondary

MeasureTime frame
Amplitude of median sensory nerve. Timepoint: At baseline, after two weeks (the end of the treatment). Method of measurement: Electromyography apparatus.;Amplitude of median motor nerve. Timepoint: At baseline, after two weeks (the end of the treatment). Method of measurement: Electromyography apparatus.;Latency of median sensory nerve. Timepoint: At baseline, after two weeks (the end of the treatment). Method of measurement: Electromyography apparatus.;Latency of median motor nerve. Timepoint: At baseline, after two weeks (the end of the treatment). Method of measurement: Electromyography apparatus.;Median nerve conduction velocity. Timepoint: At baseline, after two weeks (the end of the treatment). Method of measurement: Electromyography apparatus.;Cross sectional area of median nerve. Timepoint: At baseline, after two weeks (the end of the treatment). Method of measurement: Sonography apparatus.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAli Hossein Ghasemi

Tehran University of Medical Sciences

ghasemi.amirhossien@yahoo.com+98 21 7752 8468

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 9, 2026